TP53 and neoplasm: The finding that MAGE-A3 interacts with the ubiquitin ligase TRIM28 and thereby stimulates proteasomal degradation of the tumor suppressors p53 and AMPK [12] makes MAGE-A3 an interesting target for tumor therapy.